Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SITIME CorpSITM · Entity 1138 | See Remarks | September 11, 2026 | September 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SITIME Corp
Report date September 11, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,997 |
Reported balance
After 2026-09-11 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-11 · Sale · Disposed 3,000 · Balance 44,997 F1: Includes an aggregate of 29,322 shares of common stock issuable pursuant to previously reported restricted stock units and performance-based restricted stock units that have not vested. These unvested units include 12,698 restricted stock units that vest over time, and 16,624 performance-based restricted stock units that vest based on certain absolute and relative price performance of the issuer's common stock over various performance periods. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes an aggregate of 29,322 shares of common stock issuable pursuant to previously reported restricted stock units and performance-based restricted stock units that have not vested. These unvested units include 12,698 restricted stock units that vest over time, and 16,624 performance-based restricted stock units that vest based on certain absolute and relative price performance of the issuer's common stock over various performance periods.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CAVIUM, INC.
Report date July 06, 2018 · Filed July 06, 2018
Section 16 reporting ended · disclosed 2018-07-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2018-07-06 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2018-07-06 · Other · Disposed 7,664 · Balance 41,383 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. Row 2 · 2018-07-06 · Disposition to issuer · Disposed 34,947 · Balance 6,436 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. F2: Represents shares of common stock of the Company underlying time-based restricted stock units ("RSUs"), the vesting of which was fully accelerated immediately prior to the effective time of the Merger (the "Effective Time"). F3: Disposed of pursuant to the Merger Agreement, whereby at the Effective Time each outstanding and vested RSU and each outstanding RSU held by non-employee directors, whether vested or unvested, was converted into the right to receive (x) an amount in cash equal to the product of (A) $40.00 multiplied by (B) the number of shares of Company common stock subject to such RSU and (y) a number of shares of Marvell common stock equal to (1) 2.1757 multiplied by (2) the number of shares of Company common stock subject to such RSU. Row 3 · 2018-07-06 · Disposition to issuer · Disposed 2,461 · Balance 3,975 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. F4: Represents shares of common stock of the Company underlying performance-based restricted stock units ("PRSUs"), the vesting of which was fully accelerated immediately prior to the Effective Time. F5: Disposed of pursuant to the Merger Agreement, whereby at the Effective Time each outstanding and vested PRSU was converted into the right to receive (x) an amount in cash equal to the product of (A) $40.00 multiplied by (B) the number of shares of Company common stock subject to such PRSU and (y) a number of shares of Marvell common stock equal to (1) 2.1757 multiplied by (2) the number of shares of Company common stock subject to such PRSU. Row 4 · 2018-07-06 · Disposition to issuer · Disposed 3,975 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. F4: Represents shares of common stock of the Company underlying performance-based restricted stock units ("PRSUs"), the vesting of which was fully accelerated immediately prior to the Effective Time. F5: Disposed of pursuant to the Merger Agreement, whereby at the Effective Time each outstanding and vested PRSU was converted into the right to receive (x) an amount in cash equal to the product of (A) $40.00 multiplied by (B) the number of shares of Company common stock subject to such PRSU and (y) a number of shares of Marvell common stock equal to (1) 2.1757 multiplied by (2) the number of shares of Company common stock subject to such PRSU. |
| Stock Option Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $62.86 · Expires 2022-02-16 | Direct | 0 |
Reported balance
After 2018-07-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-07-06 · Disposition to issuer · Disposed 5,250 · Balance 0 F6: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 7) F7: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339). |
| Stock Option Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $48.88 · Expires 2023-02-11 | Direct | 0 |
Reported balance
After 2018-07-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-07-06 · Disposition to issuer · Disposed 15,365 · Balance 0 F6: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 7) F7: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339). |
| Stock Option Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $65.80 · Expires 2024-02-10 | Direct | 0 |
Reported balance
After 2018-07-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-07-06 · Disposition to issuer · Disposed 11,464 · Balance 0 F6: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 7) F7: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339). |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018.
F2: Represents shares of common stock of the Company underlying time-based restricted stock units ("RSUs"), the vesting of which was fully accelerated immediately prior to the effective time of the Merger (the "Effective Time").
F3: Disposed of pursuant to the Merger Agreement, whereby at the Effective Time each outstanding and vested RSU and each outstanding RSU held by non-employee directors, whether vested or unvested, was converted into the right to receive (x) an amount in cash equal to the product of (A) $40.00 multiplied by (B) the number of shares of Company common stock subject to such RSU and (y) a number of shares of Marvell common stock equal to (1) 2.1757 multiplied by (2) the number of shares of Company common stock subject to such RSU.
F4: Represents shares of common stock of the Company underlying performance-based restricted stock units ("PRSUs"), the vesting of which was fully accelerated immediately prior to the Effective Time.
F5: Disposed of pursuant to the Merger Agreement, whereby at the Effective Time each outstanding and vested PRSU was converted into the right to receive (x) an amount in cash equal to the product of (A) $40.00 multiplied by (B) the number of shares of Company common stock subject to such PRSU and (y) a number of shares of Marvell common stock equal to (1) 2.1757 multiplied by (2) the number of shares of Company common stock subject to such PRSU.
F6: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 7)
F7: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 29, 2022 Filed Dec 1, 2022 22:03 UTC | SITIME Corp SITM · Entity 1138 | GiftCommon Stock | 1,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001451809-22-000080 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,098 F1 · shares: On November 29, 2022, the Reporting Person made a bona fide gift for donation purposes of 1,401 shares of the Issuer's common stock to Fidelity Charitable. The reportable securities are owned directly by Fidelity Charitable, and the Reporting Person does not have voting or investment power over the shares. F2 · balance_after: Includes an aggregate of 71,088 shares of common stock issuable pursuant to previously reported restricted stock units and performance-based restricted stock units and that have not vested. Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 23:34 UTC | SITIME Corp SITM · Entity 1138 | Tax withholdingCommon Stock | 2,720 | $105.12 | $285,926.40 |
DisclosureSEC source: 0001451809-22-000072 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,499 F1 · balance_after: Includes an aggregate of 71,088 shares of common stock issuable pursuant to previously reported restricted stock units and performance-based restricted stock units and that have not vested. Read SEC document |
| August 19, 2022 Filed Aug 24, 2022 01:10 UTC | SITIME Corp SITM · Entity 1138 | Tax withholdingCommon Stock | 3,008 | $122.21 | $367,607.68 |
DisclosureSEC source: 0001451809-22-000067 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,219 F1 · balance_after: Includes an aggregate of 76,573 shares of common stock issuable pursuant to previously reported restricted stock units and performance-based restricted stock units and that have not vested. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 22:17 UTC | SITIME Corp SITM · Entity 1138 | GrantCommon Stock | 598 | $0.00 | $0.00 |
DisclosureSEC source: 0001451809-22-000061 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,227 F1 · shares: Restricted stock unit award under the Executive Bonus and Retention Plan vesting as to 50% of the shares on August 20, 2022 and the remaining 50% of the shares on February 20, 2023. F2 · balance_after: Includes an aggregate of 82,638 shares of common stock issuable pursuant to previously reported restricted stock units and performance-based restricted stock units and that have not vested. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 22:13 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 500 | $225.00 | $112,500.00 |
DisclosureSEC source: 0001451809-22-000041 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,629 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. F2 · balance_after: Includes an aggregate of 82,040 shares of common stock issuable pursuant to previously reported restricted stock units and performance-based restricted stock units and that have not vested. Read SEC document |
| May 20, 2022 Filed Jun 2, 2022 01:52 UTC | SITIME Corp SITM · Entity 1138 | Tax withholdingCommon Stock | 2,719 | $198.22 | $538,960.18 |
DisclosureSEC source: 0001451809-22-000037 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,129 F1 · balance_after: Includes an aggregate of 82,040 shares of common stock issuable pursuant to previously reported restricted stock units and performance-based restricted stock units and that have not vested. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:31 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 500 | $225.00 | $112,500.00 |
DisclosureSEC source: 0001451809-22-000023 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,848 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. F2 · balance_after: Includes an aggregate of 87,524 shares of common stock issuable pursuant to the performance-based restricted stock units and previously reported restricted stock units that have not vested. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 00:04 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 58 | $187.77 | $10,890.66 |
DisclosureSEC source: 0001451809-22-000015 · primary_doc.xml · nonDerivative · entry 2 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,348 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of previously awarded RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · balance_after: Includes an aggregate of 87,524 shares of common stock issuable pursuant to the performance-based restricted stock units and previously reported restricted stock units that have not vested. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:04 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 2,333 | $181.91 | $424,396.03 |
DisclosureSEC source: 0001451809-22-000015 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,406 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of previously awarded RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.29 to $185.31 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 06, 2022 Filed Feb 8, 2022 21:41 UTC | SITIME Corp SITM · Entity 1138 | GrantCommon Stock | 15,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001451809-22-000004 · primary_doc.xml · nonDerivative · entry 2 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,739 F2 · shares: Each performance-based restricted stock unit represents a contingent right to receive one share of common stock. The performance rights vest upon SiTime's common stock achieving specified prices per share. F3 · balance_after: Includes an aggregate of 93,766 shares of common stock issuable pursuant to the performance-based restricted stock units and previously reported restricted stock units that have not vested. Read SEC document |
| February 06, 2022 Filed Feb 8, 2022 21:41 UTC | SITIME Corp SITM · Entity 1138 | GrantCommon Stock | 565 | $0.00 | $0.00 |
DisclosureSEC source: 0001451809-22-000004 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,159 F1 · shares: Restricted stock unit award under the Executive Bonus and Retention Plan vesting as to 50% of the shares on February 20, 2022 and the remaining 50% of the shares on August 20, 2022. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:58 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 250 | $234.73 | $58,682.50 |
DisclosureSEC source: 0001451809-22-000001 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,594 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. F2 · balance_after: Includes an aggregate of 77,621 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| December 17, 2021 Filed Dec 18, 2021 01:10 UTC | SITIME Corp SITM · Entity 1138 | GrantCommon Stock | 2,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001451809-21-000105 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,844 F1 · shares: Restricted stock unit award vesting in equal quarterly installments over four years starting February 20, 2022 and, on each May 20, August 20, November 20, and February 20, thereafter. F2 · balance_after: Includes an aggregate of 77,621 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| November 29, 2021 Filed Nov 30, 2021 00:10 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 1,755 | $314.27 | $551,543.85 |
DisclosureSEC source: 0001451809-21-000093 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,898 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $310.00 to $317.50 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes an aggregate of 74,675 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 02:09 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 2,960 | $255.52 | $756,339.20 |
DisclosureSEC source: 0001451809-21-000086 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,653 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of previously awarded RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.77 to $263.96 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes an aggregate of 74,675 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| October 21, 2021 Filed Oct 22, 2021 20:21 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 150 | $225.00 | $33,750.00 |
DisclosureSEC source: 0001451809-21-000079 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,613 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. F2 · balance_after: Includes an aggregate of 79,975 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 20:11 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 150 | $220.15 | $33,022.50 |
DisclosureSEC source: 0001451809-21-000077 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,763 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. F2 · balance_after: Includes an aggregate of 79,975 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 22:27 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 1,971 | $211.47 | $416,807.37 |
DisclosureSEC source: 0001451809-21-000074 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,913 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.00 to $213.00 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes an aggregate of 79,975 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested Read SEC document |
| August 24, 2021 Filed Aug 25, 2021 22:45 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 135 | $203.30 | $27,445.50 |
DisclosureSEC source: 0001451809-21-000071 · primary_doc.xml · nonDerivative · entry 2 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,884 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of previously awarded RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · balance_after: Includes an aggregate of 79,975 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 22:45 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 3,030 | $203.08 | $615,332.40 |
DisclosureSEC source: 0001451809-21-000071 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,019 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of previously awarded RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.62 to $212.63 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 21:46 UTC | SITIME Corp SITM · Entity 1138 | GrantCommon Stock | 951 | $0.00 | $0.00 |
DisclosureSEC source: 0001451809-21-000058 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,049 F1 · shares: Restricted stock unit award under the Executive Bonus and Retention Plan vesting as to 50% of the shares on August 20, 2021 and the remaining 50% of the shares on February 20, 2022. F2 · balance_after: Includes an aggregate of 86,251 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:36 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 150 | $116.25 | $17,437.50 |
DisclosureSEC source: 0001451809-21-000053 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,098 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. F2 · balance_after: Includes an aggregate of 85,300 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 23:41 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 150 | $120.00 | $18,000.00 |
DisclosureSEC source: 0001451809-21-000051 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,248 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. F2 · balance_after: Includes an aggregate of 85,300 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 23:58 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 9,084 | $98.82 | $897,680.88 |
DisclosureSEC source: 0001451809-21-000040 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,398 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.00 to $99.50 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes an aggregate of 85,300 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| May 24, 2021 Filed May 25, 2021 21:36 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 9,088 | $93.74 | $851,909.12 |
DisclosureSEC source: 0001451809-21-000034 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,482 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of previously awarded RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.56 to $95.65 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes an aggregate of 85,300 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 20:09 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 150 | $100.00 | $15,000.00 |
DisclosureSEC source: 0001451809-21-000023 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,570 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. F2 · balance_after: Includes an aggregate of 106,500 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 22:13 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 150 | $101.44 | $15,216.00 |
DisclosureSEC source: 0001451809-21-000018 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,720 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. F2 · balance_after: Includes an aggregate of 106,500 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 00:09 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 224 | $115.00 | $25,760.00 |
DisclosureSEC source: 0001451809-21-000009 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,870 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of previously awarded RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes an aggregate of 106,500 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 22:27 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 150 | $126.00 | $18,900.00 |
DisclosureSEC source: 0001451809-21-000008 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,094 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. F2 · balance_after: Includes an aggregate of 107,000 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| January 21, 2021 Filed Jan 22, 2021 22:03 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 150 | $135.00 | $20,250.00 |
DisclosureSEC source: 0001451809-21-000005 · primary_doc.xml · nonDerivative · entry 2 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,244 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. F3 · balance_after: Includes an aggregate of 107,000 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:03 UTC | SITIME Corp SITM · Entity 1138 | GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001451809-21-000005 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,394 F1 · kind: Restricted stock unit award under the Executive Bonus and Retention Plan vesting as to 50% of the shares on February 20, 2021 and the remaining 50% of the shares on August 20, 2021. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 21:20 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 100 | $110.09 | $11,009.00 |
DisclosureSEC source: 0001451809-20-000053 · primary_doc.xml · nonDerivative · entry 2 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,394 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. F2 · balance_after: Includes an aggregate of 106,000 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 21:20 UTC | SITIME Corp SITM · Entity 1138 | SaleCommon Stock | 3,900 | $110.00 | $429,000.00 |
DisclosureSEC source: 0001451809-20-000053 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,494 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 automatic trading plan adopted by the Reporting Person. Read SEC document |
| June 17, 2020 Filed Jun 17, 2020 20:27 UTC | SITIME Corp SITM · Entity 1138 | Tax withholdingCommon Stock | 1,606 | $35.69 | $57,318.14 |
DisclosureSEC source: 0001451809-20-000011 · primary_doc.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,394 F1 · kind: Represents shares withheld by the issuer to satisfy payment of the issuer's tax withholding obligations on 4,000 restricted stock units that were granted effective June 8, 2020 and which became fully vested on June 8, 2020. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 21:57 UTC | SITIME Corp SITM · Entity 1138 | GrantCommon Stock | 106,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-015841 · doc4.xml · nonDerivative · entry 2 Pangrazio Vincent P · CIK 0001514114 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,000 F2 · shares: Represents restricted stock unit award vesting over five years, with 20% vesting on May 20, 2021, and 1/20 vesting in equal quarterly installments on each May 20, August 20, November 20 and February 20, thereafter. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 21:57 UTC | SITIME Corp SITM · Entity 1138 | GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-015841 · doc4.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 F1 · shares: Represents fully vested restricted stock units awarded to Mr. Pangrazio in connection with his appointment as EVP, Chief Legal Officer and Corporate Secretary of SiTime Corporation. Read SEC document |
| July 06, 2018 Filed Jul 6, 2018 17:38 UTC | CAVIUM, INC. CAVM · Entity 165173 | Disposition to issuerStock Option Right to Buy · Derivative | 11,464 | Not disclosed Strike: $65.80 | Not disclosed |
DisclosureSEC source: 0001209191-18-041897 · doc4.xml · derivative · entry 7 Pangrazio Vincent P · CIK 0001514114 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,464 shares Expires 2024-02-10 F6 · price: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 7) F7 · price: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339). F6 · derivative.exercise_date: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 7) F7 · derivative.exercise_date: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339). Read SEC document |
| July 06, 2018 Filed Jul 6, 2018 17:38 UTC | CAVIUM, INC. CAVM · Entity 165173 | Disposition to issuerStock Option Right to Buy · Derivative | 15,365 | Not disclosed Strike: $48.88 | Not disclosed |
DisclosureSEC source: 0001209191-18-041897 · doc4.xml · derivative · entry 6 Pangrazio Vincent P · CIK 0001514114 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,365 shares Expires 2023-02-11 F6 · price: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 7) F7 · price: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339). F6 · derivative.exercise_date: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 7) F7 · derivative.exercise_date: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339). Read SEC document |
| July 06, 2018 Filed Jul 6, 2018 17:38 UTC | CAVIUM, INC. CAVM · Entity 165173 | Disposition to issuerStock Option Right to Buy · Derivative | 5,250 | Not disclosed Strike: $62.86 | Not disclosed |
DisclosureSEC source: 0001209191-18-041897 · doc4.xml · derivative · entry 5 Pangrazio Vincent P · CIK 0001514114 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,250 shares Expires 2022-02-16 F6 · price: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 7) F7 · price: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339). F6 · derivative.exercise_date: Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 7) F7 · derivative.exercise_date: calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339). Read SEC document |
| July 06, 2018 Filed Jul 6, 2018 17:38 UTC | CAVIUM, INC. CAVM · Entity 165173 | Disposition to issuerCommon Stock | 3,975 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-041897 · doc4.xml · nonDerivative · entry 4 Pangrazio Vincent P · CIK 0001514114 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · date: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. F4 · shares: Represents shares of common stock of the Company underlying performance-based restricted stock units ("PRSUs"), the vesting of which was fully accelerated immediately prior to the Effective Time. F5 · shares: Disposed of pursuant to the Merger Agreement, whereby at the Effective Time each outstanding and vested PRSU was converted into the right to receive (x) an amount in cash equal to the product of (A) $40.00 multiplied by (B) the number of shares of Company common stock subject to such PRSU and (y) a number of shares of Marvell common stock equal to (1) 2.1757 multiplied by (2) the number of shares of Company common stock subject to such PRSU. F5 · price: Disposed of pursuant to the Merger Agreement, whereby at the Effective Time each outstanding and vested PRSU was converted into the right to receive (x) an amount in cash equal to the product of (A) $40.00 multiplied by (B) the number of shares of Company common stock subject to such PRSU and (y) a number of shares of Marvell common stock equal to (1) 2.1757 multiplied by (2) the number of shares of Company common stock subject to such PRSU. Read SEC document |
| July 06, 2018 Filed Jul 6, 2018 17:38 UTC | CAVIUM, INC. CAVM · Entity 165173 | Disposition to issuerCommon Stock | 2,461 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-041897 · doc4.xml · nonDerivative · entry 3 Pangrazio Vincent P · CIK 0001514114 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,975 F1 · date: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. F4 · shares: Represents shares of common stock of the Company underlying performance-based restricted stock units ("PRSUs"), the vesting of which was fully accelerated immediately prior to the Effective Time. F5 · shares: Disposed of pursuant to the Merger Agreement, whereby at the Effective Time each outstanding and vested PRSU was converted into the right to receive (x) an amount in cash equal to the product of (A) $40.00 multiplied by (B) the number of shares of Company common stock subject to such PRSU and (y) a number of shares of Marvell common stock equal to (1) 2.1757 multiplied by (2) the number of shares of Company common stock subject to such PRSU. F5 · price: Disposed of pursuant to the Merger Agreement, whereby at the Effective Time each outstanding and vested PRSU was converted into the right to receive (x) an amount in cash equal to the product of (A) $40.00 multiplied by (B) the number of shares of Company common stock subject to such PRSU and (y) a number of shares of Marvell common stock equal to (1) 2.1757 multiplied by (2) the number of shares of Company common stock subject to such PRSU. Read SEC document |
| July 06, 2018 Filed Jul 6, 2018 17:38 UTC | CAVIUM, INC. CAVM · Entity 165173 | Disposition to issuerCommon Stock | 34,947 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-041897 · doc4.xml · nonDerivative · entry 2 Pangrazio Vincent P · CIK 0001514114 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,436 F1 · date: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. F2 · shares: Represents shares of common stock of the Company underlying time-based restricted stock units ("RSUs"), the vesting of which was fully accelerated immediately prior to the effective time of the Merger (the "Effective Time"). F3 · shares: Disposed of pursuant to the Merger Agreement, whereby at the Effective Time each outstanding and vested RSU and each outstanding RSU held by non-employee directors, whether vested or unvested, was converted into the right to receive (x) an amount in cash equal to the product of (A) $40.00 multiplied by (B) the number of shares of Company common stock subject to such RSU and (y) a number of shares of Marvell common stock equal to (1) 2.1757 multiplied by (2) the number of shares of Company common stock subject to such RSU. F3 · price: Disposed of pursuant to the Merger Agreement, whereby at the Effective Time each outstanding and vested RSU and each outstanding RSU held by non-employee directors, whether vested or unvested, was converted into the right to receive (x) an amount in cash equal to the product of (A) $40.00 multiplied by (B) the number of shares of Company common stock subject to such RSU and (y) a number of shares of Marvell common stock equal to (1) 2.1757 multiplied by (2) the number of shares of Company common stock subject to such RSU. Read SEC document |
| July 06, 2018 Filed Jul 6, 2018 17:38 UTC | CAVIUM, INC. CAVM · Entity 165173 | OtherCommon Stock | 7,664 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-041897 · doc4.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,383 F1 · date: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. F1 · shares: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. F1 · price: Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 16:21 UTC | CAVIUM, INC. CAVM · Entity 165173 | Exercise / conversionStock option right to buy · Derivative | 6,000 | $0.00 Strike: $37.83 | $0.00 |
DisclosureSEC source: 0001209191-18-018496 · doc4.xml · derivative · entry 5 Pangrazio Vincent P · CIK 0001514114 · SVP,Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 6,000 shares Expires 2021-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/8th of the shares subject to the option vest on the six month anniversary of the grant date and 1/48th of the shares vest monthly thereafter over the next three and one half years. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 16:21 UTC | CAVIUM, INC. CAVM · Entity 165173 | Exercise / conversionStock option right to buy · Derivative | 11,363 | $0.00 Strike: $37.63 | $0.00 |
DisclosureSEC source: 0001209191-18-018496 · doc4.xml · derivative · entry 4 Pangrazio Vincent P · CIK 0001514114 · SVP,Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 11,363 shares Expires 2020-03-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/8th of the shares subject to the option vest on the six month anniversary of the grant date and 1/48th of the shares vest monthly thereafter over the next three and one half years. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 16:21 UTC | CAVIUM, INC. CAVM · Entity 165173 | SaleCommon stock | 20,777 | $90.08 | $1,871,592.16 |
DisclosureSEC source: 0001209191-18-018496 · doc4.xml · nonDerivative · entry 3 Pangrazio Vincent P · CIK 0001514114 · SVP,Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,072 F1 · kind: The sale was made under a 10b5-1 trading plan as adopted by the reporting person. F2 · price: Shares were sold ranging from $90.00 per share to $90.43 per share. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 16:21 UTC | CAVIUM, INC. CAVM · Entity 165173 | Exercise / conversionCommon stock | 6,000 | $37.83 | $226,980.00 |
DisclosureSEC source: 0001209191-18-018496 · doc4.xml · nonDerivative · entry 2 Pangrazio Vincent P · CIK 0001514114 · SVP,Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 16:21 UTC | CAVIUM, INC. CAVM · Entity 165173 | Exercise / conversionCommon stock | 11,363 | $37.63 | $427,589.69 |
DisclosureSEC source: 0001209191-18-018496 · doc4.xml · nonDerivative · entry 1 Pangrazio Vincent P · CIK 0001514114 · SVP,Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 16:29 UTC | CAVIUM, INC. CAVM · Entity 165173 | Exercise / conversionStock option right to buy · Derivative | 1,637 | $0.00 Strike: $37.63 | $0.00 |
DisclosureSEC source: 0001209191-18-015033 · doc4.xml · derivative · entry 5 Pangrazio Vincent P · CIK 0001514114 · SVP,Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,363 Underlying: Common stock · 1,637 shares Expires 2020-03-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/8th of the shares subject to the option vest on the six month anniversary of the grant date and 1/48th of the shares vest monthly thereafter over the next three and one half years. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 16:29 UTC | CAVIUM, INC. CAVM · Entity 165173 | Exercise / conversionStock option right to buy · Derivative | 500 | $0.00 Strike: $37.83 | $0.00 |
DisclosureSEC source: 0001209191-18-015033 · doc4.xml · derivative · entry 4 Pangrazio Vincent P · CIK 0001514114 · SVP,Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common stock · 500 shares Expires 2021-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/8th of the shares subject to the option vest on the six month anniversary of the grant date and 1/48th of the shares vest monthly thereafter over the next three and one half years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.